Litcius/Paper detail

Engineered low-pathogenic Helicobacter pylori as orally tumor immunomodulators for the stimulation of systemic immune response

Zishan Zeng, Yue Sun, Jingwen Jiang, Xiaoyu Xu, Huan-Xin Lin, Wanzhen Li, Dong Zheng, Yanjuan Huang, Chunshun Zhao

2024Biomaterials12 citationsDOI

Topics & Concepts

Helicobacter pyloriImmune systemCancerCancer researchStomachTumor microenvironmentCancer cellMedicineImmunologyBiologyInternal medicineCancer Research and TreatmentsHelicobacter pylori-related gastroenterology studiesBacteriophages and microbial interactions
Engineered low-pathogenic Helicobacter pylori as orally tumor immunomodulators for the stimulation of systemic immune response | Litcius